Bridgeway Capital Management’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-16,348
Closed -$1K 1502
2018
Q2
$1K Hold
16,348
﹤0.01% 1406
2018
Q1
$2K Hold
16,348
﹤0.01% 1376
2017
Q4
$2K Hold
16,348
﹤0.01% 1385
2017
Q3
$3K Hold
16,348
﹤0.01% 1388
2017
Q2
$5K Hold
16,348
﹤0.01% 1409
2017
Q1
$10K Hold
16,348
﹤0.01% 1382
2016
Q4
$11K Hold
16,348
﹤0.01% 1398
2016
Q3
$13K Hold
16,348
﹤0.01% 1418
2016
Q2
$8K Hold
16,348
﹤0.01% 1426
2016
Q1
$10K Hold
16,348
﹤0.01% 1424
2015
Q4
$23K Hold
16,348
﹤0.01% 1418
2015
Q3
$14K Hold
16,348
﹤0.01% 1455
2015
Q2
$18K Hold
16,348
﹤0.01% 1486
2015
Q1
$33K Hold
16,348
﹤0.01% 1463
2014
Q4
$18K Buy
+16,348
New +$17.7K ﹤0.01% 1448

Bridgeway Capital Management's BTX.WS Position: Q3 2018 in Review

Bridgeway Capital Management sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 16,348 shares — an estimated $1K sold.

Bridgeway Capital Management first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $33K in Q1 2015. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • Bridgeway Capital Management reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • Bridgeway Capital Management sold 16,348 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018, an estimated $1K.
  • Bridgeway Capital Management first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
  • Bridgeway Capital Management's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $33K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on Bridgeway Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.